Latest blog articles
-
The development of Genetically Modified Organisms (GMOs), nanotechnology and neonicotinoid insecticides presents opportunities for humans and the environment, but it can also carry risks to human, animal or plant health.
-
Globally the majority of health-related R&D is invested in medicines with substantial guaranteed returns, yet what is missing is extensive R&D targeted at diseases overwhelmingly prevalent in developing countries. This threatens long-term availability of medicines and treatment options for these...